| Drug Name: | Debrisoquin (1131-64-2) |
|---|---|
| PubChem ID: | 2966 |
| SMILES: | C1CN(CC2=CC=CC=C21)C(=N)N |
| InchiKey: | JWPGJSVJDAJRLW-UHFFFAOYSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 175.235 |
| LogP | : | 0.93817 |
| Ring Count | : | 1 |
| Hydrogen Bond Acceptor Count | : | 1 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 53.11 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Hypertension | MetaADEDB |
| Hypotension | MetaADEDB |
| Hypotension Orthostatic | MetaADEDB |
| Myocardial Infarction | MetaADEDB |